Tom Hayes, the former trader who became the face of the Libor scandal, won a last-ditch appeal to clear his name, undoing one ...

The U.S. Food and Drug Administration is turning its attention to selective serotonin reuptake inhibitors, a class of antidepressant drugs long criticized by Health and Human Services ...

Britain’s Supreme Court has quashed the convictions of two financial market traders accused of manipulating benchmark ...

BRUSSELS] UBS Group lost the crux of its case against European Union regulators over Credit Suisse Group’s involvement in a ...